Integrated Systems Pharmacology Analysis of Clinical Drug‐Induced Peripheral Neuropathy
dc.contributor.author | Hur, J | en_US |
dc.contributor.author | Guo, AY | en_US |
dc.contributor.author | Loh, WY | en_US |
dc.contributor.author | Feldman, EL | en_US |
dc.contributor.author | Bai, JPF | en_US |
dc.date.accessioned | 2015-01-07T15:22:46Z | |
dc.date.available | WITHHELD_5_MONTHS | en_US |
dc.date.available | 2015-01-07T15:22:46Z | |
dc.date.issued | 2014-05 | en_US |
dc.identifier.citation | Hur, J; Guo, AY; Loh, WY; Feldman, EL; Bai, JPF (2014). "Integrated Systems Pharmacology Analysis of Clinical Drug‐Induced Peripheral Neuropathy." CPT: Pharmacometrics & Systems Pharmacology 3(5): 1-11. | en_US |
dc.identifier.issn | 2163-8306 | en_US |
dc.identifier.issn | 2163-8306 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/109792 | |
dc.publisher | Wiley Periodicals, Inc. | en_US |
dc.publisher | Springer | en_US |
dc.title | Integrated Systems Pharmacology Analysis of Clinical Drug‐Induced Peripheral Neuropathy | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Pharmacy and Pharmacology | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/109792/1/psp4201411.pdf | |
dc.identifier.doi | 10.1038/psp.2014.11 | en_US |
dc.identifier.source | CPT: Pharmacometrics & Systems Pharmacology | en_US |
dc.identifier.citedreference | LaPointe, N.E., Morfini, G., Brady, S.T., Feinstein, S.C., Wilson, L. & Jordan, M.A. Effects of eribulin, vincristine, paclitaxel and ixabepilone on fast axonal transport and kinesin‐1 driven microtubule gliding: implications for chemotherapy‐induced peripheral neuropathy. Neurotoxicology 37, 231 – 239 ( 2013 ). | en_US |
dc.identifier.citedreference | Huang, d.a.W., Sherman, B.T. & Lempicki, R.A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4, 44 – 57 ( 2009 ). | en_US |
dc.identifier.citedreference | Huang da, W., Sherman, B.T. & Lempicki, R.A. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 37, 1 – 13 ( 2009 ). | en_US |
dc.identifier.citedreference | NIH GeneReviews book. < http://www.ncbi.nlm.nih.gov/books/NBK1116/ >. Accessed 25 November 2012. | en_US |
dc.identifier.citedreference | Leandro‐García, L.J. et al. Genome‐wide association study identifies ephrin type A receptors implicated in paclitaxel induced peripheral sensory neuropathy. J. Med. Genet. 50, 599 – 605 ( 2013 ). | en_US |
dc.identifier.citedreference | Oguri, T. et al. Genetic polymorphisms associated with oxaliplatin‐induced peripheral neurotoxicity in Japanese patients with colorectal cancer. Int. J. Clin. Pharmacol. Ther. 51, 475 – 481 ( 2013 ). | en_US |
dc.identifier.citedreference | Leandro‐García, L.J. et al. Regulatory polymorphisms in β‐tubulin IIa are associated with paclitaxel‐induced peripheral neuropathy. Clin. Cancer Res. 18, 4441 – 4448 ( 2012 ). | en_US |
dc.identifier.citedreference | Won, H.H. et al. Polymorphic markers associated with severe oxaliplatin‐induced, chronic peripheral neuropathy in colon cancer patients. Cancer 118, 2828 – 2836 ( 2012 ). | en_US |
dc.identifier.citedreference | Broyl, A. et al. Mechanisms of peripheral neuropathy associated with bortezomib and vincristine in patients with newly diagnosed multiple myeloma: a prospective analysis of data from the HOVON‐65/GMMG‐HD4 trial. Lancet Oncol. 11, 1057 – 1065 ( 2010 ). | en_US |
dc.identifier.citedreference | Richardson, P.G. et al. Management of treatment‐emergent peripheral neuropathy in multiple myeloma. Leukemia 26, 595 – 608 ( 2012 ). | en_US |
dc.identifier.citedreference | Smith, J.A. et al. Eribulin binds at microtubule ends to a single site on tubulin to suppress dynamic instability. Biochemistry 49, 1331 – 1337 ( 2010 ). | en_US |
dc.identifier.citedreference | Poruchynsky, M.S., Sackett, D.L., Robey, R.W., Ward, Y., Annunziata, C. & Fojo, T. Proteasome inhibitors increase tubulin polymerization and stabilization in tissue culture cells: a possible mechanism contributing to peripheral neuropathy and cellular toxicity following proteasome inhibition. Cell Cycle 7, 940 – 949 ( 2008 ). | en_US |
dc.identifier.citedreference | Staff, N.P. et al. Bortezomib alters microtubule polymerization and axonal transport in rat dorsal root ganglion neurons. Neurotoxicology 39, 124 – 131 ( 2013 ). | en_US |
dc.identifier.citedreference | Carlson, K. & Ocean, A.J. Peripheral neuropathy with microtubule‐targeting agents: occurrence and management approach. Clin. Breast Cancer 11, 73 – 81 ( 2011 ). | en_US |
dc.identifier.citedreference | Knox, C. et al. DrugBank 3.0: a comprehensive resource for ‘omics’ research on drugs. Nucleic Acids Res. 39, D1035 – D1041 ( 2011 ). | en_US |
dc.identifier.citedreference | Zhu, F. et al. Therapeutic target database update 2012: a resource for facilitating target‐oriented drug discovery. Nucleic Acids Res. 40, D1128 – D1136 ( 2012 ). | en_US |
dc.identifier.citedreference | Loh, W.‐Y. Regression trees with unbiased variable selection and interaction detection. Stat. Sinica 12, 361 – 386 ( 2002 ). | en_US |
dc.identifier.citedreference | Loh, W.‐Y. Variable selection for classification and regression in large p, small n problems. In Probability Approximations and Beyond (eds. Barbour, A et al. 135 – 159 ( Springer New York, 2012 ). | en_US |
dc.identifier.citedreference | Paice, J.A. Clinical challenges: chemotherapy‐induced peripheral neuropathy. Semin. Oncol. Nurs. 25, S8 – S19 ( 2009 ). | en_US |
dc.identifier.citedreference | Gaist, D., García Rodríguez, L.A., Huerta, C., Hallas, J. & Sindrup, S.H. Are users of lipid‐lowering drugs at increased risk of peripheral neuropathy? Eur. J. Clin. Pharmacol. 56, 931 – 933 ( 2001 ). | en_US |
dc.identifier.citedreference | Ferrier, J., Pereira, V., Busserolles, J., Authier, N. & Balayssac, D. Emerging trends in understanding chemotherapy‐induced peripheral neuropathy. Curr. Pain Headache Rep. 17, 364 ( 2013 ). | en_US |
dc.identifier.citedreference | Wheeler, H.E. et al.; Cancer and Leukemia Group B. Integration of cell line and clinical trial genome‐wide analyses supports a polygenic architecture of Paclitaxel‐induced sensory peripheral neuropathy. Clin. Cancer Res. 19, 491 – 499 ( 2013 ). | en_US |
dc.identifier.citedreference | Leandro‐García, L.J. et al. Genome‐wide association study identifies ephrin type A receptors implicated in paclitaxel induced peripheral sensory neuropathy. J. Med. Genet. 50, 599 – 605 ( 2013 ). | en_US |
dc.identifier.citedreference | Baldwin, R.M. et al. A genome‐wide association study identifies novel loci for paclitaxel‐induced sensory peripheral neuropathy in CALGB 40101. Clin. Cancer Res. 18, 5099 – 5109 ( 2012 ). | en_US |
dc.identifier.citedreference | National Cancer Institute. Common Terminology Criteria for Adverse Events v4.03 (CTCAE). < http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010‐06‐14_QuickReference_8.5x11.pdf > | en_US |
dc.identifier.citedreference | Drugs@FDA. < http://www.accessdata.fda.gov/scripts/cder/drugsatfda/ >. Accessed 25 November 2012. | en_US |
dc.identifier.citedreference | The Gene Ontology. < http://www.geneontology.org/ >. | en_US |
dc.identifier.citedreference | Kuhn, M., Campillos, M., Letunic, I., Jensen, L.J. & Bork, P. A side effect resource to capture phenotypic effects of drugs. Mol. Syst. Biol. 6, 343 ( 2010 ). | en_US |
dc.identifier.citedreference | Su, G., Kuchinsky, A., Morris, J.H., States, D.J. & Meng, F. GLay: community structure analysis of biological networks. Bioinformatics 26, 3135 – 3137 ( 2010 ). | en_US |
dc.identifier.citedreference | Chatr‐Aryamontri, A. et al. The BioGRID interaction database: 2013 update. Nucleic Acids Res. 41, D816 – D823 ( 2013 ). | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.